Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Calliditas Therapeutics AB (publ)
  6. News
  7. Summary
    CALTX   SE0010441584

CALLIDITAS THERAPEUTICS AB (PUBL)

(CALTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about CALLIDITAS THERAPEUTICS AB (PUBL)
01/14CALLIDITAS THERAPEUTICS : Amendment to Annual Report by Foreign Issuer (Form 20-F/A)
PU
2021Biologics by McKesson - TARPEYOTM (budesonide) delayed release capsules, FDA Approved t..
AQ
2021European ADRs Move Lower in Monday Trading
MT
2021HC Wainwright Adjusts Calliditas Therapeutics' Price Target to $62 From $52, Reiterates..
MT
2021Citigroup Adjusts Calliditas Therapeutics' Price Target to $84 From $51, Reiterates Buy..
MT
2021AFTER HOURS WATCH LIST SCORECARD : Calt, blbd, irnt
MT
2021CALLIDITAS THERAPEUTICS : FDA grants Calliditas Therapeutics Accelerated Approval of TARPE..
PU
2021Health Care Stocks Marginally Higher on Thursday
MT
2021Health Care Stocks Rise Marginally Thursday Afternoon
MT
2021European ADRs Move Higher in Thursday Trading
MT
2021FDA grants Calliditas Therapeutics Accelerated Approval of TARPEYO (budesonide) to Redu..
AQ
2021Health Care Stocks Cautiously Higher Pre-Bell Thursday
MT
2021Calliditas Receives FDA Approval for Tarpeyo for Primary IgA Nephropathy -- Shares Cata..
MT
2021MT NEWSWIRES AFTER HOURS WATCH LIST : Calt, blbd, irnt
MT
2021Calliditas Receives FDA Approval for Tarpeyo for Primary IgA Nephropathy
MT
More most relevant news
All news about CALLIDITAS THERAPEUTICS AB (PUBL)
01/14CALLIDITAS THERAPEUTICS : Amendment to Annual Report by Foreign Issuer (Form 20-F/A)
PU
01/10European ADRs Move Lower in Monday Trading
MT
2021Biologics by McKesson - TARPEYOTM (budesonide) delayed release capsules, FDA Approved t..
AQ
2021European ADRs Move Higher in Tuesday Trading
MT
2021European ADRs Move Lower in Monday Trading
MT
2021HC Wainwright Adjusts Calliditas Therapeutics' Price Target to $62 From $52, Reiterates..
MT
2021Citigroup Adjusts Calliditas Therapeutics' Price Target to $84 From $51, Reiterates Buy..
MT
2021AFTER HOURS WATCH LIST SCORECARD : Calt, blbd, irnt
MT
2021CALLIDITAS THERAPEUTICS : FDA grants Calliditas Therapeutics Accelerated Approval of TARPE..
PU
2021Health Care Stocks Marginally Higher on Thursday
MT
More news
News in other languages on CALLIDITAS THERAPEUTICS AB (PUBL)
01/10Les ADR européens en baisse lundi
2021Les ADR européens en hausse mardi
2021Les ADR européens en baisse lundi
2021Les actions du secteur de la santé en légère hausse jeudi
2021Les actions du secteur de la santé connaissent une hausse marginale jeudi après-midi
2021Les ADR européens sont en hausse jeudi
2021Les actions du secteur de la santé en hausse prudente avant la cloche de jeudi
2021Calliditas reçoit l'approbation de la FDA pour Tarpeyo dans le traitement de la néphrop..
2021Calliditas reçoit l'approbation de la FDA pour Tarpeyo dans le traitement de la néphrop..
2021Les ADR européens en légère baisse dans les échanges de mercredi
More news
Analyst Recommendations on CALLIDITAS THERAPEUTICS AB (PUBL)
2021HC Wainwright Adjusts Calliditas Therapeutics' Price Target to $62 From $52, Reiterates..
MT
2021Citigroup Adjusts Calliditas Therapeutics' Price Target to $84 From $51, Reiterates Buy..
MT
2021ANALYST RECOMMENDATIONS : Alibaba, Goldman Sachs, Monday.com, Shaftesbury, 3M Company...
More recommendations
Press releases
01/14CALLIDITAS THERAPEUTICS : Amendment to Annual Report by Foreign Issuer (Form 20-F/A)
PU
2021Biologics by McKesson - TARPEYOTM (budesonide) delayed release capsules, FDA Approved t..
AQ
2021CALLIDITAS THERAPEUTICS : FDA grants Calliditas Therapeutics Accelerated Approval of TARPE..
PU
2021FDA grants Calliditas Therapeutics Accelerated Approval of TARPEYO (budesonide) to Redu..
AQ
2021CALLIDITAS THERAPEUTICS : FDA grants Calliditas Therapeutics Accelerated Approval of TARPE..
PU
More press releases
Upcoming event on CALLIDITAS THERAPEUTICS AB (PUBL)
02/24/22